Direct chemical synthesis has been adapted to make oligonucleotides of remarkable length, including an 800 nucleotide green ...

Pfizer Inc. today announced positive results from the Phase 3 TALAPRO-2 study of TALZENNA® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI® (enzalutamide ...

Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction ... and revenue surprises of 3.03% and 1.63%, respectively, for the quarter ...

Using a new technology and computational method, researchers from Fred Hutch Cancer Center and The University of Texas MD ...

STONY BROOK, NY / ACCESS Newswire / February 11, 2025 /Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the ...

STONY BROOK, NY / ACCESS Newswire / February 11, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today issued a reminder to it ...

Stanford Medicine is the first to offer the new blood test for mold infections deep inside the body, sparing patients from tissue biopsies.

Guardant Health is overcoming skepticism with new cancer tests. Learn why GH stock is a buy, with strong growth and a shift ...

The overall market of herpes simplex is expected to boost with the expected launch of emerging therapy, increased awareness, and extensive research in the forecast period (2025-2034). LAS ...

Researchers determined the clinical classification of more than 90% of potential BRCA2 variants of uncertain significance in ...